Company / FCF Margin
ResMed FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
32.3%
FY2025
5-year range
6.0% / 32.3%
FY2021-FY2025
Trend
+16.2%
vs FY2024
Sector context
#3 of 139
Health Care
What the data says
Among 139 Health Care companies, ResMed is in the top 2% for fcf margin. FCF Margin has increased for 3 consecutive years, from 6.0% in FY2022 to 32.3% in FY2025.
Based on SEC 10-K filings.
32.3% in FY2025 with a 5-year CAGR of +8.4%. Ranks 3rd among 139 companies in Health Care.
Improved from 13.6% to 32.3% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +26.2pp
- 5-Year Change
- +8.4pp
- 10-Year Change
- -
Sector benchmark
Top 2% in Health CareTop 2% of 139This company 32.3% Sector average -217.0%
▼
+114.9% above sector average
Key checks
Key Insights
- ResMed's fcf margin has grown for 3 consecutive years.
- In FY2025, fcf margin increased 16.2% year-over-year.
- Currently 249.3pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 32.3% | +16.2% |
| FY2024 | 27.8% | +104.6% |
| FY2023 | 13.6% | +124.5% |
| FY2022 | 6.0% | -69.5% |
| FY2021 | 19.8% | -17.1% |
| FY2020 | 23.9% | +59.6% |
| FY2019 | 15.0% | -20.8% |
| FY2018 | 18.9% | +11.1% |
| FY2017 | 17.0% | -36.1% |
| FY2016 | 26.6% | +39.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026